Click on one of these terms to refine your search
1 to 9 of 9 literature results
Glioblastomas are highly aggressive primary brain tumors. Curative treatment by surgery and radiotherapy is generally impossible due to the presence o…
Authors: An Claes, Pieter Wesseling, Judith Jeuken, Cathy Maass, Arend Heerschap, William P J Leenders
Source: Molecular cancer therapeutics. 2008 Jan
View Full TextAberrant RAS/RAF signaling has been reported to be important for many tumor types including gliomas. Activation of the RAS/RAF pathway can result from…
Authors: Judith Jeuken, Caroline van den Broecke, Sabine Gijsen, Sandra Boots-Sprenger, Pieter Wesseling
Source: Acta neuropathologica. 2007 Aug
View Full TextRecently, exclusive loss of paternal 19q alleles in six of six oligodendrogliomas has been reported, indicating that parental imprinting plays a role …
Authors: Christian Hartmann, Wolf Mueller, Ulrike Lass, Florian Stockhammer, Kajetan von Eckardstein, Julian Veelken, Judith Jeuken, Wolfgang Wick, Andreas von Deimling
Source: Annals of neurology. 2003 Aug
View Full TextBACKGROUND: Malignant gliomas of the central nervous system remain associated with dismal prognoses because of their diffuse invasion of the brain par…
Authors: Fabrice Branle, Florence Lefranc, Isabelle Camby, Judith Jeuken, Anneke Geurts-Moespot, Sandra Sprenger, Fred Sweep, Robert Kiss, Isabelle Salmon
Source: Cancer. 2002 Aug 1
View Full TextEpidermal growth factor receptor (EGFR) is commonly affected in cancer, generally in the form of an increase in DNA copy number and/or as mutation var…
Authors: Judith Jeuken, Angelique Sijben, Cristina Alenda, Jos Rijntjes, Marieke Dekkers, Sandra Boots-Sprenger, Roger McLendon, Pieter Wesseling
Source: Brain pathology (Zurich, Switzerland). 2009 Oct
View Full TextGenetic aberrations in tumors are predictive for chemosensitivity and survival. A test is needed that allows simultaneous detection of multiple change…
Authors: Judith Jeuken, Sandra Cornelissen, Sandra Boots-Sprenger, Sabine Gijsen, Pieter Wesseling
Source: The Journal of molecular diagnostics : JMD. 2006 Sep
View Free Full TextThe chromosome (chr) 1p deletion is a favorable biomarker in oligodendroglial tumors and is even more powerful a marker when combined with chr 19q los…
Authors: Ahmed Idbaih, Mathilde Kouwenhoven, Judith Jeuken, Catherine Carpentier, Thierry Gorlia, Johan M Kros, Pim French, Johannes L Teepen, Olivier Delattre, Jean-Yves Delattre,…
Source: Neuropathology : official journal of the Japanese Society of Neuropathology. 2008 Aug
View Full TextVon Hippel-Lindau (VHL) disease is an autosomal dominant tumor syndrome, in which hemangioblastomas (HBs), clear cell renal cell carcinomas (RCCs), an…
Authors: Johanna Gijtenbeek, Bram Jacobs, Sandra Boots-Sprenger, Anita Bonne, Jacques Lenders, Benno Küsters, Pieter Wesseling, Judith Jeuken
Source: Diagnostic molecular pathology : the American journal of surgical pathology, part B. 2005 Jun
View Full TextSinonasal mucosal melanomas are the most frequent mucosal melanomas and arise from melanocytes located in the nasal cavity and the paranasal sinuses. …
Authors: Marcory van Dijk, Sandra Sprenger, Paul Rombout, Henri Marres, Johannes Kaanders, Judith Jeuken, Dirk Ruiter
Source: Genes, chromosomes & cancer. 2003 Feb
View Full Text